Filing Details
- Accession Number:
- 0001645470-19-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-18 17:22:19
- Reporting Period:
- 2019-01-15
- Accepted Time:
- 2019-01-18 17:22:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,651,123 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 2,500 | $0.03 | 20,653,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 10,000 | $0.03 | 20,663,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,668,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 10,000 | $0.03 | 20,678,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,683,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,688,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,693,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 2,000 | $0.03 | 20,695,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 2,000 | $0.03 | 20,697,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 10,000 | $0.03 | 20,707,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,712,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,717,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,722,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,727,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,732,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,737,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,742,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,747,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 10,000 | $0.03 | 20,757,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,762,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 5,000 | $0.03 | 20,767,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 5,000 | $0.03 | 20,772,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 5,000 | $0.03 | 20,777,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 5,000 | $0.03 | 20,782,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 5,000 | $0.03 | 20,787,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 10,000 | $0.03 | 20,797,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 5,000 | $0.03 | 20,802,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 5,000 | $0.03 | 20,807,623 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
